首页|基于社会认知理论的冠心病经皮冠状动脉介入术后Ⅱ期远程家庭心脏康复方案的构建

基于社会认知理论的冠心病经皮冠状动脉介入术后Ⅱ期远程家庭心脏康复方案的构建

扫码查看
目的 构建基于社会认知理论(SCT)的冠心病(CHD)经皮冠状动脉介入术(PCI)后患者Ⅱ期远程家庭心脏康复(HBCR)方案.方法 基于循证文献检索、小组讨论构建基于SCT的CHD行PCI后患者Ⅱ期HBCR方案初稿,应用德尔菲法专家咨询形成终稿.结果 共对18名专家进行了 3轮专家函询,3轮函询的专家权威系数分别为0.86、0.87、0.87,肯德尔和谐系数分别为0.211、0.242、0.271,差异均有统计学意义(P<0.01).形成的CHD行PCI后患者Ⅱ期HBCR方案包括综合评估、纠正康复认知、完善社会支持、实施路径4个一级条目,10个二级条目,以及27个三级条目.结论 本研究构建的CHD行PCI后患者Ⅱ期远程HBCR方案具有科学性、可靠性,或可为HBCR护理提供指导.
Establishment of a phase Ⅱ remote home-based cardiac rehabilitation program for patients with coronary heart disease after percutaneous coronary intervention based on social cognitive theory
Objective To establish a phase Ⅱ remote home-based cardiac rehabilitation(HBCR)program for patients with coronary heart disease(CHD)after percutaneous coronary inter-vention(PCI)based on social cognitive theory(SCT).Methods A preliminary draft of the phaseⅡ HBCR program for CHD patients after PCI based on SCT was developed through evidence-based literature review and group discussion,and the final version was formed through Delphi expert consul-tation.Results A total of 18 experts participated in three rounds of expert consultation.The expert authority coefficients for the three rounds were 0.86,0.87 and 0.87 respectively,and the Kendall's W coefficients were 0.211,0.242 and 0.271 respectively,with significant differences(P<0.01).The final phase Ⅱ HBCR program for CHD patients after PCI included four primary items:compre-hensive assessment,correction of rehabilitation cognition,improvement of social support,and imple-mentation pathway,with 10 secondary items and 27 tertiary items.Conclusion Phase Ⅱ remote HBCR program for CHD patients after PCI constructed in this study is scientific and reliable,and may provide guidance for HBCR nursing.

coronary heart diseasepercutaneous coronary interventionDelphi methodhome-based cardiac rehabilitationsocial cognitive theory

戴玲、周建伟、郑明香、彭兰芳

展开 >

湖南师范大学医学院,湖南长沙,410013

湖南师范大学附属岳阳医院,湖南长沙,410013

冠心病 经皮冠状动脉介入术 德尔菲法 家庭心脏康复 社会认知理论

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(22)